374Water Inc (NASDAQ:SCWO, FRA:8LL) announced that it has appointed Stephen McKnight to its board of directors, as the cleantech company continues to advance its corporate growth strategy.
McKnight is a principal and co-founder of Pitt Southwest Investors, a private real estate and development firm established in 1989.
Broker Cavendish says additional US protection strengthens long-term outlook and reiterates buy rating.
Shares in Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) jumped as much 11% earlier in the session after the company said US regulators had granted an additional three years of data exclusivity for its oral iron therapy Accrufer.
EDM Resources Inc (TSX-V:EDM, OTC:SWNLF) said it has submitted a Fisheries Act Authorization (FAA) application to Canada’s Department of Fisheries and Oceans, a key federal regulatory step required to extend the main pit at its Scotia Mine in Nova Scotia.
The Vancouver-based miner said the submission follows more than three years of additional permitting work and includes environmental, engineering and consultation materials aimed at securing approval for the pit extension.
Namibia survey to enhance prospect mapping on PEL 93 ahead of future drilling campaign
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ), an oil and gas exploration company listed in London and Sydney, has said that recent exploration success in Namibia's Damara Fold Belt has strengthened the case for its planned airborne geophysical survey on Petroleum Exploration Licence 93.
Shares in Phoenix Copper Ltd (AIM:PXC, OTCQX:PXCLF, FRA:5HR) fell 45% to 1.1p after the US-focused base and precious metals producer said it had suspended its executive chairman and chief financial officer with immediate effect.
In a stock exchange statement, Phoenix said chair Marcus Edwards-Jones and CFO and company secretary Richard Wilkins were subject to the suspension.
Rainbow Rare Earths Ltd told investors that its large-scale pilot plant recently commissioned in Johannesburg is operating the optimised Phalaborwa primary flowsheet in line with expectations and has successfully produced approximately 2 kg of high-grade mixed rare earth hydroxide, which is a commercial product.
The mixed rare earth product is approximately 55% TREO, higher than the industry norm of 42-44% TREO according to Chinese specifications for mixed rare earth carbonate, it noted.
Western Yilgarn NL (ASX:WYX, OTC:WYGXF) has flagged a new high-grade gallium–tellurium target at its Ida Holmes Junction Project in WA’s Northern Goldfields after rock-chip sampling returned standout surface assays across two widely spaced exploration licences.
The early-stage discovery includes gallium grades of up to 185.5 parts per million (ppm) alongside elevated tellurium values. Western Yilgarn said the mineralisation has now been confirmed across Exploration Licences E36/1020 and E36/1046, which are about 39 kilometres apart, suggesting the potential for a large, regionally extensive system rather than isolated occurrences.
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) last week outlined progress on its lead oncology asset HMBD-002, positioning the immunotherapy program to move into Phase II clinical testing following the completion of Phase I studies.
Chief executive officer Dr James Garner said the company had undergone a significant reset, both in terms of its asset base and internal structure, describing HMBD-002 as a completely new opportunity for Percheron Therapeutics Ltd. He noted that the drug had no scientific relationship to previous programs and targets a different disease pathway, making it uncorrelated with earlier setbacks.